Volume 133, Issue 3, Pages (September 2007)

Slides:



Advertisements
Similar presentations
Volume 130, Issue 4, Pages (April 2006)
Advertisements

Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response  Henry Lik–Yuen Chan, Vincent.
Volume 138, Issue 1, Pages e1 (January 2010)
Volume 139, Issue 2, Pages (August 2010)
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
Volume 143, Issue 4, Pages e4 (October 2012)
Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.
Volume 137, Issue 5, Pages (November 2009)
Volume 131, Issue 3, Pages (September 2006)
Volume 140, Issue 2, Pages (February 2011)
Volume 137, Issue 4, Pages (October 2009)
Volume 141, Issue 4, Pages e6 (October 2011)
Volume 154, Issue 3, Pages e8 (February 2018)
Volume 137, Issue 3, Pages e7 (September 2009)
Volume 142, Issue 5, Pages e3 (May 2012)
Volume 143, Issue 4, Pages e9 (October 2012)
Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase  Chia–Ming Chu, Yi–Cheng Chen, Dar–In.
Outcomes Among Living Liver Donors
Volume 128, Issue 2, Pages (February 2005)
Making Sense of HDAC2 Mutations in Colon Cancer
Kinetics of Intrahepatic Covalently Closed Circular DNA and Serum Hepatitis B Surface Antigen During Antiviral Therapy for Chronic Hepatitis B: Lessons.
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Volume 68, Issue 3, Pages (March 2018)
Volume 129, Issue 3, Pages (September 2005)
Volume 139, Issue 4, Pages e3 (October 2010)
Volume 136, Issue 2, Pages (February 2009)
Volume 135, Issue 4, Pages (October 2008)
Volume 133, Issue 5, Pages (November 2007)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B  W.-K. Seto, D. K.-H. Wong,
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency  Danny Ka-Ho Wong, Wai-Kay.
Volume 143, Issue 6, Pages e4 (December 2012)
Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors  Dominique Challine, Stéphane Chevaliez,
Volume 133, Issue 5, Pages (November 2007)
This Month in Gastroenterology
Volume 135, Issue 1, Pages (July 2008)
Volume 130, Issue 4, Pages (April 2006)
Volume 127, Issue 5, Pages (November 2004)
Volume 136, Issue 4, Pages (April 2009)
Volume 154, Issue 6, Pages (May 2018)
Volume 135, Issue 2, Pages (August 2008)
Volume 134, Issue 7, Pages e2 (June 2008)
Volume 139, Issue 2, Pages (August 2010)
Volume 132, Issue 3, Pages (March 2007)
Volume 136, Issue 7, Pages (June 2009)
Ahmad S. Abdulkarim, Hong Cao, Bing Huang, Mark A. McNiven 
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 138, Issue 2, Pages e4 (February 2010)
Volume 138, Issue 1, Pages e1 (January 2010)
Volume 130, Issue 4, Pages (April 2006)
Christoph Sarrazin, Stefan Zeuzem  Gastroenterology 
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins  Harel Dahari, Stephen M. Feinstone,
Volume 132, Issue 7, Pages (June 2007)
Issue Highlights Clinical Gastroenterology and Hepatology
Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review  Gennaro D’Amico, Juan Carlos Garcia-Pagan,
Volume 137, Issue 5, Pages (November 2009)
Covering the Cover Gastroenterology
Correlation of FIBROSpect II With Histologic and Morphometric Evaluation of Liver Fibrosis in Chronic Hepatitis C  Keyur Patel, David R. Nelson, Don C.
Volume 143, Issue 6, Pages e8 (December 2012)
Volume 140, Issue 7, Pages e2 (June 2011)
Immune Quiescence and Hepatitis B Virus: Tolerance Has Its Limits
Volume 128, Issue 3, Pages (March 2005)
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Volume 121, Issue 5, Pages (November 2001)
Volume 139, Issue 5, Pages e3 (November 2010)
Serum HBV pgRNA as a clinical marker for cccDNA activity
Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response  Henry Lik–Yuen Chan, Vincent.
Yun-Fan Liaw, Wen-Juei Jeng, Ming-Ling Chang  Gastroenterology 
Volume 135, Issue 1, Pages (July 2008)
Reply Gastroenterology
Volume 138, Issue 2, Pages e4 (February 2010)
Presentation transcript:

Volume 133, Issue 3, Pages 843-852 (September 2007) Impaired Intrahepatic Hepatitis B Virus Productivity Contributes to Low Viremia in Most HBeAg-Negative Patients  Tassilo Volz, Marc Lutgehetmann, Paul Wachtler, Anna Jacob, Alexander Quaas, John M. Murray, Maura Dandri, Joerg Petersen  Gastroenterology  Volume 133, Issue 3, Pages 843-852 (September 2007) DOI: 10.1053/j.gastro.2007.06.057 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Relationship between viral titers and intrahepatic viral loads in HBeAg-positive and HBeAg-negative patients. Correlation between HBV DNA in serum and amounts of (A) intrahepatic rcDNA per cell or (B) intrahepatic cccDNA per cell. Dots represent single patient measurements. Open dots represent HBeAg-negative (n = 77) and closed dots represent HBeAg-positive patients (n = 42). Linear regression lines were determined by Pearson correlations. In B, correlations are displayed separately (solid line for HBeAg positive and dashed line for HBeAg-negative patients). r (Spearman rank) and P values are indicated. Gastroenterology 2007 133, 843-852DOI: (10.1053/j.gastro.2007.06.057) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 HBeAg-negative patients have significantly lower viral productivity. (A) Intrahepatic levels of rcDNA per cccDNA in the liver of HBeAg-positive (n = 42) and HBeAg-negative patients (n = 77). (B) Ratios of pgRNA to cccDNA measured in random liver biopsy specimens from 17 of 42 HBeAg-positive and 43 of 77 HBeAg-negative patients. Median levels are indicated by bars and were 49 versus 9 rcDNA/cccDNA and 214 versus 38 pgRNA/cccDNA in HBeAg-positive and HBeAg-negative patients, respectively. Dots represent single patient measurements. (C) Relationship between intrahepatic amounts of pgRNA and rcDNA measured in each liver biopsy sample. Linear regression lines were determined by Pearson correlations. r and P values are indicated. Gastroenterology 2007 133, 843-852DOI: (10.1053/j.gastro.2007.06.057) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Production and secretion of subviral particles is not impaired in HBeAg-negative patients. (A) Serum HBsAg concentrations normalized for cccDNA contents measured in the liver of corresponding patients. Median values (bars) were 25 and 70 μg/mL serum in HBeAg-positive and HBeAg-negative individuals, respectively. Each dot represents a single patient measurement. (B) Intrahepatic levels of subgenomic preS/S RNA per cccDNA molecules determined in the same biopsy samples. Median values are 357 (HBeAg positive) versus 768 (HBeAg negative) preS/S RNA copies/cccDNA. Gastroenterology 2007 133, 843-852DOI: (10.1053/j.gastro.2007.06.057) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Relationship between HBsAg concentrations in serum and intrahepatic levels of cccDNA. Box plots represent 3 groups of patients with different HBsAg concentrations as indicated. Shown are the 25th, 50th, and 75th percentiles of patients with log HBV cccDNA copies/cell. Median cccDNA levels were 0.07, 0.3, and 1.8 cccDNA copies/cell in groups 1, 2, and 3, respectively. By applying the Mann–Whitney test, we found that differences between groups were highly significant (group 1 vs 2, P = .004; group 2 vs 3, P < .0001). Gastroenterology 2007 133, 843-852DOI: (10.1053/j.gastro.2007.06.057) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Accumulation of BCP mutations restores high viral productivity and increases viremia in HBeAg-negative patients. (A) Comparison of virion productivity (rcDNA/cccDNA) between HBeAg-positive and HBeAg-negative patients harboring the same pattern of PC/BCP mutations. Box plots show comparison of HBeAg-positive (white boxes) and HBeAg-negative (gray boxes) patients without emergence of HBeAg variants (group 1; P < .0001), harboring cccDNA pools with both wild-type and PC mutations (group 2) or with BCP variants (group 3) or with PC + BCP mutants (group 4). Median virion productivity in HBeAg-negative patients in groups 2, 3, and 4 was significantly lower (P = .004) compared with HBeAg-positive patients within the same groups. Among HBeAg-negative patients, significantly higher ratios (P = .002) of rcDNA to cccDNA levels were found in 6 patients without detectable wild-type cccDNA sequences in the PC and BCP regions (group 5). Shown are the 25th, 50th, and 75th percentiles of patients with log rcDNA/cccDNA. The number of patients in each group is indicated. (B) Comparison of log rcDNA levels produced per cccDNA among patients displaying similar viremia. Three groups of viremia ranges are indicated. Median rcDNA/cccDNA levels were 64 and 5.7 in group 1 (P = NS), 59 and 10.6 in group 2 (P = .014), and 36 and 70.6 in group 3 (P = NS) by comparing HBeAg-positive (white boxes) and HBeAg-negative patients (light gray boxes), respectively. HBeAg-negative patients without detectable wild-type cccDNA sequences in the PC and BCP regions are shown in groups 1 (n = 1) and 2 (n = 5, dark gray box) and had a median of 176 rcDNA/cccDNA. Gastroenterology 2007 133, 843-852DOI: (10.1053/j.gastro.2007.06.057) Copyright © 2007 AGA Institute Terms and Conditions